Citadel Advisors
AVAH icon

Citadel Advisors’s Aveanna Healthcare AVAH Stock Holding History

Citadel Advisors’s Portfolio AVAH Stock Details AVAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,000
Closed -$195K – 12634
2025
Q3 		$195K Buy
+22,000
New +$139K ﹤0.01% 11289
2025
Q1 		– Sell
-200
Closed -$914 – 14439
2024
Q4 		$914 Buy
200
+100
+100% +$512 ﹤0.01% 14255
2024
Q3 		$520 Sell
100
-1,000
-91% -$4.52K ﹤0.01% 14003
2024
Q2 		$3.04K Buy
1,100
+800
+267% +$1.99K ﹤0.01% 13629
2024
Q1 		$747 Buy
+300
New +$724 ﹤0.01% 14256
2023
Q1 		– Sell
-2,500
Closed -$1.95K – 14684
2022
Q4 		$1.95K Buy
+2,500
New +$2.62K ﹤0.01% 14394

Other funds holding AVAH

BCI
Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return
JHWEPV
J.H. Whitney Equity Partners VII New Canaan, Connecticut $233M AUM 18.82% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
LC
Littlejohn & Co Greenwich, Connecticut $106M AUM 7.38% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Citadel Advisors's AVAH Position: Q1 2026 in Review

Citadel Advisors reduced its Aveanna Healthcare (AVAH) stake by 82% in Q1 2026, selling an estimated $9.84M and leaving 276,950 shares worth $1.78M. The position accounts for ﹤0.01% of the portfolio, ranked #6324.

Citadel Advisors first reported a position in AVAH in Q2 2021 and has held it in 16 quarters since. The position peaked at $16M in Q2 2021. 198 funds tracked by Wall St. Rank hold AVAH as of Q1 2026.

  • Citadel Advisors held 276,950 shares of Aveanna Healthcare worth $1.78M as of Q1 2026.
  • Citadel Advisors sold 1,272,844 Aveanna Healthcare shares in Q1 2026, an estimated $9.84M.
  • Aveanna Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #6324 holding.
  • Citadel Advisors first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 16 quarters since.
  • Citadel Advisors's Aveanna Healthcare position peaked at $16M in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.